Impact of provider volume on outcomes of patients with Hodgkin lymphoma.
Catherine G. Ireland(Brigham and Women's Hospital), Michael G. Martin(University of Tennessee Health Science Center), Jason C. Chandler(West Cancer Center), Monika L. Metzger(St. Jude Children's Research Hospital), Muhammad M. Mirza(University of Tennessee Health Science Center), Alexandria Tran(University of Tennessee Health Science Center)
Cited by 0
Related Papers
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|655
Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study
|The Lancet Oncology|2015|210
Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study
|The Lancet Child & Adolescent Health|2021|134
Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study
|The Lancet Oncology|2021|134
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017
|Journal of the National Comprehensive Cancer Network|2017|62